Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
about
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cellsImmunologic aspect of ovarian cancer and p53 as tumor antigen.Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarrayTranslating tumor antigens into cancer vaccinesRecombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides.Genetic profile of head and neck squamous cell carcinoma: clinical implications.Immunotherapy in head and neck cancer: current practice and future possibilities.Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerAntigen-specific vaccines for cancer treatment.Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
P2860
Q24804892-F3350783-3C99-43F2-90C6-B15AEEC1EEF3Q24814703-23E922DC-1ABA-459B-9AD3-29A6D7C16075Q28235811-18F843BA-046D-4E12-ABC8-BA8E69A1E586Q34484042-7C1D2405-123B-4443-B110-3E3BE9447A7AQ35677112-0F39957D-7CDB-4FF4-8C4F-96296691F93AQ36973865-356E7106-6326-433A-92B1-1EB5F232EEE5Q37241209-8DE9876C-2489-421E-A77B-E1356F076F72Q37257768-16363D93-0DC4-4D32-9EC4-6FE09C32EC73Q37259621-8C26B57A-4A86-4B24-96DB-B8DF8AD2C073Q37584313-56C958C0-E6C2-455C-9209-58DEF2F1E365Q38284692-2D2A24AB-628D-4641-88F7-7D15A280B15AQ40085654-AC655D25-7F48-4DB2-A686-39ACEF24D609Q40399680-E8A9268F-96D9-4ED7-8BEA-5684D591D89AQ44269708-C6BEC674-414D-47B1-BC76-147C94A914BFQ51013344-2118E6B0-7303-4A7C-A117-FC13E5DE3A41
P2860
Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Generation of cytotoxic T cell ...... de derived from wild-type p53.
@en
type
label
Generation of cytotoxic T cell ...... de derived from wild-type p53.
@en
prefLabel
Generation of cytotoxic T cell ...... de derived from wild-type p53.
@en
P2093
P2860
P356
P1476
Generation of cytotoxic T cell ...... de derived from wild-type p53.
@en
P2093
P2860
P2888
P304
P356
10.1054/BJOC.2000.1715
P407
P577
2001-04-01T00:00:00Z
P5875
P6179
1038230477